Opportunity Information: Apply for PAR 07 341

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "HIV Treatment Adherence Research (R34)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants.
  • This funding opportunity was created on Dec 5, 2008 and posted on Mar 27, 2007.
  • Applicants must submit their applications by Multiple Receipt Dates See Link to Full Announcement for details.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $225,000.00 in funding.
  • Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) For profit organizations other than small businesses Special district governments Public and State controlled institutions of higher education County governments Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education City or township governments State governments.
  • Foreign institutions are eligible to apply.
Apply for PAR 07 341

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The HIV Treatment Adherence Research (R34) opportunity, Funding Opportunity Number PAR-07-341, is a National Institutes of Health grant announcement led by the National Institute of Mental Health (NIMH). Its main goal is to support exploratory work that advances the science behind improving adherence to HIV treatment, with an emphasis on mental health interventions and service approaches that can realistically strengthen how consistently people take and stay on antiretroviral therapy. In practical terms, the FOA is aimed at early-stage or preparatory intervention research that helps move promising adherence strategies toward stronger, larger-scale testing and eventual implementation, especially where mental health, behavior, and service delivery factors shape adherence outcomes.

This announcement uses the R34 mechanism, described here as the NIMH Exploratory Grants for Mental Health Interventions and Services. The R34 is generally designed to help researchers develop, refine, and pilot-test interventions and related service models before committing to a full-scale efficacy or effectiveness trial. The FOA also notes that it runs in parallel with several other NIH announcements covering the same broad scientific space but using different funding mechanisms: PA-07-338 (R01 Research Project Grant), PA-07-339 (R03 Small Research Grant), and PA-07-340 (R21 Exploratory/Developmental). The presence of these parallel options signals that NIH anticipated projects at different stages of maturity, from small preliminary studies (R03), to developmental innovation (R21), to more definitive trials (R01), with this R34 sitting in the space of intervention and services development and preparation for later-stage research.

In terms of funding, the opportunity lists an award ceiling of $225,000, and it explicitly states that awards depend on the availability of funds and on receiving enough high-quality, competitive applications. Rather than guaranteeing a set number of awards, NIMH is indicating that funding decisions will be made based on merit and budget realities in the relevant fiscal periods. The FOA is categorized as a discretionary grant in the health area, and it is tied to CFDA 93.242 (Mental Health Research Grants). There is no cost-sharing or matching requirement, which means applicants are not required to provide non-federal matching funds as a condition of receiving an award.

Eligibility is broad and includes many types of domestic U.S. organizations and governments as well as foreign institutions. Eligible applicants listed include nonprofits with or without 501(c)(3) status, public and private institutions of higher education, for-profit organizations (including those other than small businesses), small businesses, state and local governments (including county and city/township governments), special district governments, independent school districts, public housing authorities/Indian housing authorities, and Native American tribal organizations, including federally recognized tribal governments. The FOA specifically notes that foreign institutions are eligible to apply, which expands participation beyond the U.S. and can support adherence research in international contexts where HIV treatment programs and adherence barriers may differ.

From an administrative and timing standpoint, this opportunity was posted on March 27, 2007, with multiple receipt dates rather than a single one-time deadline, meaning applicants could submit according to recurring NIH submission cycles during the active period of the announcement. The listing indicates an archive date of February 7, 2010, which means it is no longer an active, open FOA today, but it remains useful as a reference for the type of HIV adherence intervention development work NIMH sought to support through the R34 mechanism during that period. The full announcement was made available through the NIH grants guide, and the contact provided for technical access issues is the NIH Office of Extramural Research (OER) webmaster.

Overall, PAR-07-341 was designed to stimulate and support early, intervention-focused mental health services research that could measurably improve HIV treatment adherence, using the R34 structure to help applicants build the evidence base, procedures, and readiness needed for more definitive follow-on studies under larger NIH mechanisms.

FAQs: HIV Treatment Adherence Research (R34) - PAR-07-341

What is the HIV Treatment Adherence Research (R34) opportunity (PAR-07-341)?

PAR-07-341 is a National Institutes of Health (NIH) grant announcement for HIV Treatment Adherence Research using the R34 mechanism. It was led by the National Institute of Mental Health (NIMH) and focused on exploratory work to improve adherence to HIV treatment, particularly through mental health interventions and service approaches that can realistically strengthen consistent use of antiretroviral therapy.

Which NIH institute led this funding opportunity?

The opportunity was led by the National Institute of Mental Health (NIMH).

What is the main purpose of this FOA?

The main purpose was to support early-stage or preparatory intervention research that advances the science of improving adherence to HIV treatment. The emphasis is on mental health interventions and service delivery approaches that could measurably improve how consistently people take and stay on antiretroviral therapy.

What does the R34 mechanism support in this announcement?

In this FOA, the R34 (NIMH Exploratory Grants for Mental Health Interventions and Services) is described as supporting the development, refinement, and pilot-testing of interventions and related service models. The intent is to help projects become ready for later, larger-scale efficacy or effectiveness trials rather than immediately funding a full-scale trial.

What stage of research was PAR-07-341 intended to fund?

It was aimed at exploratory and preparatory work, such as intervention and services development and pilot testing, to move promising HIV adherence strategies toward stronger, larger-scale testing and eventual implementation.

What scientific areas or approaches were emphasized?

The FOA emphasized adherence research where mental health, behavior, and service delivery factors shape adherence outcomes. It particularly highlighted mental health interventions and service approaches that could strengthen adherence to antiretroviral therapy in real-world conditions.

How much funding could an award provide?

The opportunity listed an award ceiling of $225,000.

Was funding guaranteed or were a set number of awards promised?

No. The FOA stated that awards would depend on the availability of funds and the receipt of a sufficient number of meritorious, competitive applications. It did not guarantee a set number of awards.

Is cost sharing or matching required?

No. The announcement states there is no cost-sharing or matching requirement, meaning applicants were not required to provide non-federal matching funds as a condition of the award.

How is this FOA categorized (grant type and area)?

It is categorized as a discretionary grant in the health area.

What CFDA number is associated with this opportunity?

The FOA is tied to CFDA 93.242 (Mental Health Research Grants).

Who was eligible to apply?

Eligibility was broad and included many U.S. domestic organizations and governments as well as foreign institutions. Eligible applicants listed include:

  • Nonprofits with or without 501(c)(3) status
  • Public and private institutions of higher education
  • For-profit organizations (including those other than small businesses)
  • Small businesses
  • State governments
  • Local governments (including county and city/township governments)
  • Special district governments
  • Independent school districts
  • Public housing authorities/Indian housing authorities
  • Native American tribal organizations, including federally recognized tribal governments
  • Foreign institutions

Are foreign (non-U.S.) institutions eligible to apply?

Yes. The FOA specifically notes that foreign institutions are eligible to apply, enabling participation in international contexts where HIV treatment programs and adherence barriers may differ.

When was PAR-07-341 posted?

The opportunity was posted on March 27, 2007.

Did this FOA have one deadline or multiple receipt dates?

It had multiple receipt dates rather than a single one-time deadline, meaning applicants could submit according to recurring NIH submission cycles during the active period of the announcement.

Is PAR-07-341 still open for applications?

No. The listing shows an archive date of February 7, 2010, indicating it is no longer an active, open FOA today.

What is the practical value of PAR-07-341 now that it is archived?

Even though it is not open, it can still be useful as a reference for the kind of HIV adherence intervention development work NIMH supported through the R34 mechanism during that period.

Were there related NIH opportunities running in parallel with this one?

Yes. The FOA noted parallel NIH announcements in the same broad scientific space using different mechanisms:

  • PA-07-338 (R01 Research Project Grant)
  • PA-07-339 (R03 Small Research Grant)
  • PA-07-340 (R21 Exploratory/Developmental)

How does this R34 relate to the parallel R01, R03, and R21 options mentioned?

The parallel options signal projects at different stages of maturity: R03 for small preliminary studies, R21 for developmental innovation, R01 for more definitive trials, and this R34 positioned around intervention and services development and preparation for later-stage research.

Where was the full announcement made available?

The full announcement was made available through the NIH grants guide.

Who was listed as the contact for technical access issues?

The contact provided for technical access issues was the NIH Office of Extramural Research (OER) webmaster.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Psychosocial/Behavioral Interventions and Services Research in Autism Spectrum Disorders (R34)

Previous opportunity: HIV Treatment Adherence Research (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 07 341

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 07 341) also looked into and applied for these:

Funding Opportunity
Collaborative Neurological Sciences (CNS) Award (S11) Apply for PAR 07 357

Funding Number: PAR 07 357
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Molecular Mechanisms of Development and Reversal of Alcohol Induced Liver Fibrosis (R01) Apply for PA 07 360

Funding Number: PA 07 360
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Molecular Mechanisms of Development and Reversal of Alcohol Induced Liver Fibrosis (R21) Apply for PA 07 361

Funding Number: PA 07 361
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIBIB Research Revisions to Promote Clinical Resident Research Experiences (Revisions to Currently Active NIBIB R01 and R37 Grants) Apply for PAR 07 363

Funding Number: PAR 07 363
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Grants for Basic Research in Glomerular Diseases (R01) Apply for PA 07 367

Funding Number: PA 07 367
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Simian Models For The Oral Biology Of HIV Infection And AIDS Related Oral Complications (R21) Apply for PA 07 369

Funding Number: PA 07 369
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implicating Noncoding RNAs in the Genetics of Mental Disorders (R01) Apply for PA 07 370

Funding Number: PA 07 370
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implicating Noncoding RNAs in the Genetics of Mental Disorders (Collaborative R01) Apply for PA 07 371

Funding Number: PA 07 371
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Implicating Noncoding RNAs in the Genetics of Mental Disorders (R21) Apply for PA 07 372

Funding Number: PA 07 372
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Investigator Initiated Multi Site Clinical Trials (R01) Apply for PAR 07 373

Funding Number: PAR 07 373
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Harmonization of Longitudinal Cross National Surveys of Aging (R21) Apply for PAS 07 387

Funding Number: PAS 07 387
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Identifying and Reducing Diabetes and Obesity Related Health Disparities within Healthcare Systems (R01) Apply for PA 07 388

Funding Number: PA 07 388
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Biology of Manual Therapies (R01) Apply for PA 07 393

Funding Number: PA 07 393
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Outcomes in Children with Mild to Severe Hearing Loss (R01) Apply for PA 07 394

Funding Number: PA 07 394
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Transfusion Related Acute Lung Injury (TRALI) Basic Research (R01) Apply for PA 07 385

Funding Number: PA 07 385
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Young Children with Mild to Severe Hearing Loss (R01) Apply for PA 07 399

Funding Number: PA 07 399
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Young Children with Mild to Severe Hearing Loss (R21) Apply for PA 07 400

Funding Number: PA 07 400
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01) Apply for PA 07 406

Funding Number: PA 07 406
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21) Apply for PA 07 407

Funding Number: PA 07 407
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03) Apply for PA 07 408

Funding Number: PA 07 408
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 07 341", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.